BNET Industries
Baxter International Inc. (BAX) is in the Health Care Industry
- Revenue
- Dec 31 2007
- $11.2B
- Profit
- Dec 31 2007
- $1.7B
- Market Cap
- Jul 22 2008
- $43.1B
Latest News and Analysis
Baxter International Inc. Q2 2008 Earnings Call Transcript
Baxter International Inc. BAX Q2 2008 Earnings Call
Earnings Preview: Baxter International
Baxter International BAX is expected to report Q2 earnings before market open on Thursday, July 17, with a conference call scheduled for 8:30 am ET. Guidance Analysts are looking for a profit of 82c on revenue of 3.05B. The consensus range is 80c to 82c for EPS, and revenue of...
Baxter International Inc. Q1 2008 Earnings Call Transcript
Baxter International Inc. Q1 2008 Earnings Call Transcript
Baxter International Q4 2007 Earnings Call Transcript
Baxter International Q4 2007 Earnings Call Transcript
Baxter Q3 2007 Earnings Call Transcript
Baxter Q3 2007 Earnings Call Transcript
Baxter International Q2 2007 Earnings Call Transcript
Baxter International Q2 2007 Earnings Call Transcript
Baxter International Inc.: Corporate Governance Guidelines
The Board of Directors of Baxter International Inc. recognizes the importance of good corporate governance as a means of addressing the needs of the Company’s stockholders, employees, customers and community. These Guidelines are intended to serve as flexible principles and to be interpreted in the context of all applicable laws...
Additional Resources
Zacks Analyst Blog Highlights: McGraw-Hill Companies, Inc., Tractor Supply Co., Regis Corp., Baxter International, Inc. and Magellan Midstream Partners, L.P
CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: McGraw-Hill Companies, Inc. (NYSE: MHP), Tractor Supply Co. (Nasdaq: TSCO), Regis...
Baxter International Second Quarter 2008 Financial Results Conference Call
DEERFIELD, Ill., July 14 /PRNewswire-FirstCall/ -- Baxter International , will host a quarterly conference call to discuss its second quarter 2008 financial results on Thursday, July 17, 2008, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). To access the call, please dial 866-238-0637 domestic or 703-639-1156 international....
Legal Technology Experts Join Interact 2008 to Discuss Agile Technology Strategies for New and Evolving Business Processes
Mitratech, a leading provider of softwaresolutions for organizations to manage legal, compliance, and securityrisks, today announced that a panel of legal technology experts will leadthe session titled, "Avoiding the Technology RFP," at Mitratech's Interact2008: The Legal and Compliance Technology Forum. David Cambria, Director of Operations, Aon Corporation; Reyner Meikle,Attorney, Litigation...
Baxter International Second Quarter 2008 Financial Results Conference Call
DEERFIELD, Ill. -- Baxter International (NYSE: BAX) will host a quarterly conference call to discuss its second quarter 2008 financial results on Thursday, July 17, 2008, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). To access the call, please dial 866-238-0637 domestic or 703-639-1156 international. Please dial into the...
Baxter Releases Ninth Annual Sustainability Report
Announces Companywide Sustainability Goals to Drive Long-Term Progress DEERFIELD, Ill., June 19 /PRNewswire-FirstCall/ -- Baxter International Inc. today released its 2007 Sustainability Report -- Our Priorities. Our Progress., which highlights the company's 2007 social, economic and environmental performance. The report features the establishment of performance...
New Analyst Reports for TENET HEALTHCARE CORPORATION, MEDTRONIC INC, BAXTER INTERNATIONAL INC, and ELAN CORP
MaybachFinancial.com is one of the fastest growingindependent and unbiased research firms in the world. Through our numerouspartnerships with many of the top investment minds in the world, we provideresearch on companies making a move in the markets. Investors seekinggenuine analyst opinions on their investments TENET HEALTHCARE CORPORATION(NYSE: THC), MEDTRONIC INC...
Scientists optimistic about bird flu vaccine
The first experimental bird flu vaccine made from lab-grown cells instead of chicken eggs shows promise in blocking the highly lethal virus, scientists report. The advance is good news not just for preparations in case of a pandemic but also because it offers a way to make...
The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine
First scientific, peer-reviewed publication showing the candidate vaccine induced neutralizing antibodies against widely divergent H5N1 virus DEERFIELD, Ill., June 11 /PRNewswire-FirstCall/ -- Baxter International Inc. announced publication in the June 12, 2008 issue of The New England Journal of Medicine NEJM of data demonstrating Baxter's candidate...
CyDex Pharmaceuticals Appoints Theron Odlaug, Ph.D. as President and Chief Operating Officer
LENEXA, Kan. -- CyDex Pharmaceuticals, Inc. today announced that Theron Ted E. Odlaug, Ph.D. has been appointed to the newly established position of president and chief operating officer. Dr. Odlaug's 30 years of experience includes senior leadership roles with Astellas, Fujisawa, Bayer AG and Baxter International and spans...
Research and Markets: Baxter International, 3M Company and Ethicon Inc Are Some of the Companies Operating in Argentina's Wound Care Management Industry
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c92396) has announced the addition of Argentina Wound Care Management Industry Report: Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supply to their offering. ...
Fitch Rates Baxter's Proposed Debt Offering 'A'; Outlook Stable
CHICAGO -- Fitch has assigned an 'A' rating to Baxter International Inc's. Baxter proposed debt offering of 10-year senior unsecured notes. Baxter intends to use the net proceeds from the sale for general corporate purposes, which may include the repayment of outstanding indebtedness and certain net investment hedges. ...
Iowa Resident Dies After Using Contaminated Blood Thinner
Illinois Pharmaceutical Manufacturer Named In Lawsuit CHICAGO, May 14 /PRNewswire/ -- Last month a lawsuit was filed against Deerfield, Illinois-based Baxter International Inc. on behalf of Davenport, Iowa resident, Mark Scott who suffered the tragic loss of his wife, Melissa Scott, on November 30, 2007. The complaint...
Illinois Pharmaceutical Manufacturer Named in Yet Another Heparin Lawsuit After Virginia Resident Dies
CHICAGO, May 14 /PRNewswire/ -- The blood thinner Heparin continues to make headlines as more people are found to have suffered serious injuries and/or death after using the contaminated drug -- a group of which appears to include several Virginia residents. On Friday May 2, 2008, a lawsuit...
- Next »
- page 1 of 55
- « Previous
Sort byClose
View Related Content by Tag Close
- Incorporated: 1931
- CEO: Mr. Robert L. Parkinson Jr.
Baxter International operates through three primary business segments. Co.'s BioScience business manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as proteins used in hemostasis, wound-sealing and tissue regeneration; and vaccines. Co.'s Medication Delivery business manufactures products used in the delivery of fluids and drugs to patients, and its Renal business provides products to treat end-stage renal disease, or irreversible kidney failure.
Key Competitors
Baxter International Inc. Company Info
Board of Directors
Mr. Robert L. Parkinson Jr.
Chairman
Mr. John D. Forsyth
Ms. Gail D. Fosler
Ms. Carole Uhrich Shapazian
General Walter E. Boomer
Mr. Thomas T. Stallkamp
Lead Director
Dr. Wayne T. Hockmeyer Ph.D.
Dr. Joseph B. Martin M.D., Ph
Mr. Albert P.L. Stroucken
Dr. James R. Gavin III, M.D
Mr. Peter S. Hellman
Mr. Kornelis J. Storm
Mr. Blake E. Devitt
Contact Information
One Baxter Parkway
Deerfield, IL
847 948-2000
